Skip to content

EMERGE HEALTH INTERNATIONAL INC: 10-Q filed 2015-05-13

What EMERGE HEALTH INTERNATIONAL INC reported in its quarterly report filed 2015-05-13 (fiscal Q3 2015): 23 published measures, 62 facts as tagged in accession 0001575872-15-000034.

This filing

Form
10-Q (quarterly report)
Filed
2015-05-13
Fiscal period
fiscal Q3 2015
Accession
0001575872-15-000034 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All EMERGE HEALTH INTERNATIONAL INC filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2015-03-311,610,915USD
At 2014-06-301,671,281USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2015-03-31260,709USD
At 2014-06-30332,243USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2015-03-311,350,206USD
At 2014-06-301,339,039USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2015-03-3173,826USD
At 2014-06-3036,836USD
At 2014-03-3172,050USD
At 2013-06-30174,650USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2015-01-01 to 2015-03-3141,148USD90
2014-07-01 to 2015-03-3111,167USD274
2014-01-01 to 2014-03-31-123,103USD90
2013-07-01 to 2014-03-31-72,681USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2015-03-31-564,797USD
At 2014-06-30-575,964USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2015-01-01 to 2015-03-311,984USD90
2014-07-01 to 2015-03-310USD274
2014-01-01 to 2014-03-31-13,496USD90
2013-07-01 to 2014-03-31-2,590USD274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2015-03-31341,964USD
At 2014-06-30379,064USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2015-01-01 to 2015-03-3146,057USD90
2014-07-01 to 2015-03-3125,690USD274
2014-01-01 to 2014-03-31-135,305USD90
2013-07-01 to 2014-03-31-67,615USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2015-03-311,022,788USD
At 2014-06-301,046,054USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2015-03-31187,008USD
At 2014-06-30237,428USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2015-03-31162,707USD
At 2014-06-30224,262USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2015-03-31750,742USD
At 2014-06-30815,192USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2015-01-01 to 2015-03-31256,334USD90
2014-07-01 to 2015-03-31609,940USD274
2014-01-01 to 2014-03-3181,852USD90
2013-07-01 to 2014-03-31529,593USD274

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2015-01-01 to 2015-03-310USD90
2014-07-01 to 2015-03-315,092USD274
2014-01-01 to 2014-03-31800USD90
2013-07-01 to 2014-03-314,930USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2015-03-3115,221,647shares
At 2014-06-3015,221,647shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2015-03-311,899,781USD
At 2014-06-301,899,773USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2015-03-311,126,154USD
At 2014-06-301,071,802USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2015-03-31246,163USD
At 2014-06-30246,163USD

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2015-01-01 to 2015-03-316,894USD90
2014-07-01 to 2015-03-3120,681USD274
2014-01-01 to 2014-03-315,958USD90
2013-07-01 to 2014-03-3115,786USD274

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2015-01-01 to 2015-03-31-1,756USD90
2014-07-01 to 2015-03-31-10,639USD274
2014-01-01 to 2014-03-31144USD90
2013-07-01 to 2014-03-3195USD274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2014-07-01 to 2015-03-3115,566USD274
2013-07-01 to 2014-03-31-51,891USD274

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2014-07-01 to 2015-03-31-64,450USD274
2013-07-01 to 2014-03-3167,891USD274

Inspect the source

Entity
EMERGE HEALTH INTERNATIONAL INC / CIK 0000032567
Captured
SEC response SHA-256
ccc4af770e79b095a8863560b1e3ccab7d296bc5e1172eb71ea3e8a8cfe03817

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000032567.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))